Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Image Index

View All
Mechanism of Leucovorin (LV) 'Rescue' in High-Dose Methotrexate (MTX)
Mechanism of Methotrexate (MTX) Breakdown Via Glucarpidase
Mechanisms of Action of Daratumumab
Mechanisms of Folic Acid in Cell Physiology
Microtubules
Mitogen-Activated Protein Kinase (MAPK)/Extracellular Signal-Related Kinase (ERK)
Molecular Effect of Estrogen on the Estrogen Receptor (ER)
Molecular Mechanism of and rogen Receptor (AR) Activation by Dihydrotestosterone (DHT)
Monoclonal Antibody Structure and Classification
Naked Monoclonal Antibody Mechanism of Action
New Active Substance Launches from 2011 to 2016 by Indication
Nitrosoureas
Normal DNA Structure Consists of Phosphate, Deoxyribose, and Base
Novel Therapeutic Strategies in Oncology
Other Nitrogen Mustards
Overview of Prostate Cancer (PC) Progression and Treatment
Parp Inhibitors Exemplify Synthetic Lethality
Pathways to Drug Development
Patient Selection and Study Design
Pharmacodynamic and Descriptive/Biological Biomarkers
Pharmacokinetic Endpoints
Pharmacokinetics: Relation to Toxicity or Achievement of Steady State
Phases of Clinical Trials
Physiological and Anatomical Targets of FDA-Approved 'Hormonal' Drugs for Prostate Cancer
Platinum Compounds
Polyglutamate 'Trapping' of Methotrexate (MTX)
Polymorphism in Thiopurine Methyltransferase (TPMT)
Predictive Biomarkers
Prevention and Management of Infusion-Related Reactions Due to Monoclonal Antibodies
Prognostic Biomarkers